Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Pandion Therapeutics, Inc. (PAND)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K |
| Revenues | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% |
| Gross profit | 100.0% | 100.0% |
| Research and development | 386.2% | 1879.6% |
| General and administrative | 145.8% | 518.1% |
| Depreciation | 5.8% | 25.0% |
| EBIT | -432.0% | -2297.7% |
| Pre-tax income | -434.0% | -2262.4% |
| Income taxes | 0.0% | 0.0% |
| Net income | -490.0% | -2673.4% |
|